In vitro culture studies of Sutherlandia frutescens on human tumor cell lines

Anfossi, 1999, Modulation of human platelet function by l-canavanine: differential effects of low and high concentrations, General Pharmacology, 32, 321, 10.1016/S0306-3623(98)00193-1 Bence, 2002, The antiproliferative and immunotoxic effects of l-canavanine and l-canaline, Anti-Cancer Drugs, 13, 313, 10.1097/00001813-200203000-00013 Bongers, 1999, One-step RT–PCR to detect cytokine/chemokine induction in macrophages, Focus, 21, 66 Collins, R.D., Cousar, J.B., Russell, W.G., Click, A.D., 1980. Diagnosis of neoplasms of the immune system. In: Rose, N.R., Friedman, H. (Eds.), Manual of Clinical Immunology, 2nd ed. American Society for Microbiology, Washington, DC, pp. 98–99. Crooks, P.A., Rosenthal, G.A, 1994. Use of l-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer. US Patent 5,552,440. Kawaii, 1999, Effect of citrus flavonoids on HL-60 cell differentiation, Anticancer Research, 19, 1261 Levy, 1999, Beneficial effects of l-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats, Shock, 11, 98, 10.1097/00024382-199902000-00005 Medical Research Council and National Research Foundation of South Africa, 2002. A toxicity study of Sutherlandia leaf powder (Sutherlandia microphylla) consumption. Final Report 2002. Miyamoto, 2002, Effect of poly-herbal formula on NO production by LPS-stimulated macrophage-like cells, Anticancer Research, 22, 3293 Morris, 2001, Treating HIV in South Africa—a tale of two systems, The Lancet, 357, 1190, 10.1016/S0140-6736(00)04401-9 Ortega, 2003, A new role for GABA: inhibition of tumor cell migration, Trends in Pharmacological Science, 24, 151, 10.1016/S0165-6147(03)00052-X Ostlund, R.E., Sherman, W.R., 1998. Pinitol and derivatives thereof for the treatment of metabolic disorders. US Patent 5,827,896. Prete, 1985, Effects of l-canavanine on immune function in normal and autoimmune mice: disordered B-cell function by a dietary amino acid in the immunoregulation of autoimmune disease, Canadian Jouranl of Physiology and Pharmacology, 63, 843, 10.1139/y85-139 Re, 1999, Antioxidant activity applying an improved ABTS radical cation decolorization assay, Free Radical Biology and Medicine, 26, 1231, 10.1016/S0891-5849(98)00315-3 Rosenthal, 1997, l-Canaline: a potent antimetabolite and anti-cancer agent from leguminous plants, Life Science, 60, 1635, 10.1016/S0024-3205(96)00595-4 Schlesier, 2002, Assessment of antioxidant activity by using different in vitro methods, Free Radical Research, 36, 177, 10.1080/10715760290006411 Suh, 1995, Discovery of natural product chemopreventive agents utilizing HL60 cell differentiation as a model, Anticancer Research, 15, 233 Torre, 2002, Role of nitric oxide in HIV-1 infection: friend or foe?, Lancet Infectious Disease, 2, 273, 10.1016/S1473-3099(02)00262-1 van Wyk, B.E., Gericke N., 2000. People’s Plants. A Guide to the Useful Plants of Southern Africa. Briza, Pretoria. van Wyk, B.E., van Oudtshoorn, B., Gericke N., 1997. Medicinal Plants of South Africa. Briza, Pretoria, pp. 246–247. Wadsworth, 1999, Effects of wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages, Biochemical Pharmacology, 57, 941, 10.1016/S0006-2952(99)00002-7 WHO Press Release, 2002. WHO launches the first global strategy on traditional and alternative medicine. WHO/38, 16 May 2002.